Daxor Overview

  • Year Founded
  • 1971

Year Founded

  • Status
  • Public

  • Employees
  • 750

Employees

  • Stock Symbol
  • DXR

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $8.46
  • (As of Thursday Closing)

Daxor General Information

Description

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system. The company operates as a single business segment centered on the development, commercialization, and support of its proprietary blood volume analysis technology used by healthcare providers.

Contact Information

Website
www.daxor.com
Formerly Known As
Idant, Idant Corporation
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 107 Meco Lane
  • Oak Ridge, TN 37830
  • United States
+1 (865)
Primary Industry
Diagnostic Equipment
Stock Exchange
NAS
Corporate Office
  • 107 Meco Lane
  • Oak Ridge, TN 37830
  • United States
+1 (865)

Daxor Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Daxor Stock Performance

As of 12-Nov-2026, Daxor’s stock price is $8.46. Its current market cap is $49.4M with 5.84M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$8.46 $8.52 $8.24 - $14.76 $49.4M 5.84M 22.2K $1.69

Daxor Financials Summary

As of 30-Jun-2026, Daxor has a trailing 12-month revenue of $8.16M.

In Thousands,
USD 		TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 60,103 74,583 38,870 46,006
Revenue 8,155 10,319 2,216 1,330
Net Income 6,229 9,170 536 281
Total Assets 51,856 46,010 36,633 34,869
Total Debt 0 730 756
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Daxor Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Daxor‘s full profile, request access.

Request a free trial

Daxor Patents

  • 59

    Total Documents Applications and Grants

  • Total Patents Families

  • 30

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

Daxor Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D1128083-S1 Vial Active 30-Nov-2023
CA-247304-S Vial for blood collection Active 30-Nov-2023
US-20250172575-A1 Quantitative blood collection vial and system and method for determining hematocrit Pending 27-Nov-2023
WO-2025072023-A1 Remote blood volume monitor Inactive 26-Sep-2023
CA-232786-S Blood volume analyzer Active 05-Jul-2023
To view Daxor’s complete patent history, request access »

Daxor Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Daxor Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Daxor‘s full profile, request access.

Request a free trial

Daxor Investments (1)

Daxor’s most recent deal was a Corporate Asset Purchase with Iso-Tex Diagnostics (Rights of Volumex and Megatope). The deal was made on 25-Mar-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Iso-Tex Diagnostics (Rights of Volumex and Megatope) 25-Mar-2024 Corporate Asset Purchase Buildings and Property
To view Daxor’s complete investments history, request access »

Ready to get started?

Request a free trial

Daxor ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

32.78 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,585

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view Daxor’s complete esg history, request access »

Daxor FAQs

  • When was Daxor founded?

    Daxor was founded in 1971.

  • Where is Daxor headquartered?

    Daxor is headquartered in Oak Ridge, TN.

  • What is the size of Daxor?

    Daxor has 750 total employees.

  • What industry is Daxor in?

    Daxor’s primary industry is Diagnostic Equipment.

  • Is Daxor a private or public company?

    Daxor is a Public company.

  • What is Daxor’s stock symbol?

    The ticker symbol for Daxor is DXR.

  • What is the current stock price of Daxor?

    As of 12-Nov-2026 the stock price of Daxor is $8.46.

  • What is the current market cap of Daxor?

    The current market capitalization of Daxor is $49.4M.

  • What is Daxor’s current revenue?

    The trailing twelve month revenue for Daxor is $8.16M.

  • What is Daxor’s annual earnings per share (EPS)?

    Daxor’s EPS for 12 months was $1.69.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process